07:30 ETEndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosisprnewswire·Mar 23 at 11:30 AMIBB+0.85%PSTV0.00%
Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climbrttnews·Dec 1, 2025 at 03:32 AMENTO0.00%BCAB-36.09%
Entero Therapeutics shares are trading lower. The company reported Q3 financial results.benzinga_article·Nov 20, 2025 at 04:53 PMENTO0.00%
Entero Therapeutics | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 19, 2025 at 10:15 PMENTO0.00%GRDX-3.76%
NASDAQ: ENTO's Grid AI Strikes Texas Hyperscale Deal as its $50M Industrial Software Platform Enters the AI RaceTip Ranks·Nov 19, 2025 at 02:00 PMENTO0.00%GRDX-3.76%
Entero Therapeutics’ Board Governance Structure UpdateTip Ranks·Nov 6, 2025 at 09:55 PMENTO0.00%GRDX-3.76%
Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid | ENTO Stock NewsStockTitan·Nov 6, 2025 at 01:45 PMENTO0.00%GRDX-3.76%
